Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C
- PMID: 28781223
- DOI: 10.1053/j.gastro.2017.04.053
Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C
Comment in
-
Reply.Gastroenterology. 2017 Sep;153(3):867. doi: 10.1053/j.gastro.2017.08.001. Epub 2017 Aug 3. Gastroenterology. 2017. PMID: 28781221 No abstract available.
Comment on
-
Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection.Gastroenterology. 2017 May;152(6):1366-1371. doi: 10.1053/j.gastro.2017.01.017. Epub 2017 Jan 27. Gastroenterology. 2017. PMID: 28137593 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
